Published in Biochem J on March 15, 1976
Energy conservation in chemotrophic anaerobic bacteria. Bacteriol Rev (1977) 30.41
Structure and function of proton-translocating adenosine triphosphatase (F0F1): biochemical and molecular biological approaches. Microbiol Rev (1983) 3.11
Properties and function of the proton-translocating adenosine triphosphatase of Clostridium perfringens. J Bacteriol (1979) 0.82
The mother-cell-membrane adenosine triphosphatase of sporulating Clostridium pasteurianum. Biochem J (1980) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem (1969) 142.11
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci (1964) 127.96
Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry (1971) 66.90
The internal-alkaline pH gradient, sensitive to uncoupler and ATPase inhibitor, in growing Clostridium pasteurianum. Eur J Biochem (1975) 2.70
Solubilization of bacterial membrane proteins using alkyl glucosides and dioctanoyl phosphatidylcholine. Biochim Biophys Acta (1975) 2.29
Purification and properties of reconstitutively active and inactive adenosinetriphosphatase from Escherichia coli. Proc Natl Acad Sci U S A (1974) 1.72
Membrane Mg-(Ca)-Activated Adenosine Triphosphatase of Escherichia coli: Characterization in the Membrane-Bound and Solubilized States. J Bacteriol (1970) 1.49
Membrane-associated ATPase activity from Micrococcus lysodeikticus. Biochim Biophys Acta (1968) 1.42
A procedure for the estimation of microgram quantities of triton X-100. Anal Biochem (1973) 1.40
The biosynthesis of granulose by Clostridium pasteurianum. Biochem J (1974) 1.37
Purification of two Clostridium bacteriocins by procedures appropriate to hydrophobic proteins. Antimicrob Agents Chemother (1975) 1.28
Action of Buytricin 7423 on Clostridium pasteurianum: changes in intracellular adenosine triphosphate concentration. Biochem Soc Trans (1975) 0.85
Membrane-bound adenosinetriphosphatase of Escherichia coli. II. Physicochemical properties of the enzyme. J Biochem (1974) 0.81
Cholera. Clin Microbiol Rev (1995) 12.33
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
Bacteriophage therapy. Antimicrob Agents Chemother (2001) 5.16
Oxygen and the growth and metabolism of Clostridium acetobutylicum. J Gen Microbiol (1971) 4.91
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Emerging foodborne pathogens: Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world. Epidemiol Rev (1996) 4.09
Harlequin syndrome: the sudden onset of unilateral flushing and sweating. J Neurol Neurosurg Psychiatry (1988) 3.47
Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect Immun (1990) 3.47
Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med (1981) 3.25
Learning and memory difficulties after environmental exposure to waterways containing toxin-producing Pfiesteria or Pfiesteria-like dinoflagellates. Lancet (1998) 3.03
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest (1987) 3.03
UBA domains of DNA damage-inducible proteins interact with ubiquitin. Nat Struct Biol (2001) 3.00
A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health (1996) 2.78
Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun (1994) 2.73
Evaluation of DNA colony hybridization and other techniques for detection of virulence in Yersinia species. J Clin Microbiol (1989) 2.58
Production of Solvents by Clostridium acetobutylicum Cultures Maintained at Neutral pH. Appl Environ Microbiol (1984) 2.51
Back pain: a randomized clinical trial of rotational manipulation of the trunk. Br J Ind Med (1974) 2.47
Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect Immun (1995) 2.45
Cloning of the cytotoxin-hemolysin gene of Vibrio vulnificus. Infect Immun (1985) 2.42
A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/. Nature (1994) 2.35
On the permeability to weak acids and bases of the cytoplasmic membrane of Clostridium pasteurianum. Biochem Biophys Res Commun (1981) 2.32
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun (1995) 2.25
Illness caused by Vibrio damsela and Vibrio hollisae. Lancet (1982) 2.17
Isolation of vancomycin-resistant enterococci from animal feed in USA. Lancet (1999) 2.12
Distribution of Vibrio vulnificus in the Chesapeake Bay. Appl Environ Microbiol (1996) 2.10
The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry (1999) 2.07
Non-O:1 Vibrio cholerae bacteremia: case report and review. Rev Infect Dis (1988) 2.07
Half-time and high-speed running in the second half of soccer. Int J Sports Med (2012) 2.03
Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol Microbiol (1996) 2.01
Comparison of DNA probes and the Sereny test for identification of invasive Shigella and Escherichia coli strains. J Clin Microbiol (1986) 1.96
A novel role of the budding yeast separin Esp1 in anaphase spindle elongation: evidence that proper spindle association of Esp1 is regulated by Pds1. J Cell Biol (2001) 1.95
Utilization of L-threonine by a species of Arthrobacter. A novel catabolic role for "aminoacetone synthase". Biochem J (1969) 1.95
Rapid identification of Vibrio vulnificus on nonselective media with an alkaline phosphatase-labeled oligonucleotide probe. Appl Environ Microbiol (1993) 1.94
Identification of environmental Vibrio vulnificus isolates with a DNA probe for the cytotoxin-hemolysin gene. Appl Environ Microbiol (1987) 1.94
The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect Immun (1991) 1.87
Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect Immun (1992) 1.86
Superoxide dismutase in some obligately anaerobic bacteria. FEBS Lett (1975) 1.85
Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J Bacteriol (1992) 1.81
The cytolysin gene of Vibrio vulnificus: sequence and relationship to the Vibrio cholerae E1 Tor hemolysin gene. Infect Immun (1990) 1.79
Facial sweating in Horner's syndrome. Brain (1984) 1.73
Development and testing of a nonradioactive DNA oligonucleotide probe that is specific for Vibrio cholerae cholera toxin. J Clin Microbiol (1992) 1.71
Investigation of an outbreak of Salmonella enteritidis gastroenteritis associated with consumption of eggs in a restaurant chain in Maryland. Am J Epidemiol (1988) 1.71
Molecular techniques in the study of Salmonella typhi in epidemiologic studies in endemic areas: comparison with Vi phage typing. Am J Trop Med Hyg (1986) 1.68
Seroprevalence of Helicobacter pylori in Seventh-Day Adventists and other groups in Maryland. Lack of association with diet. Arch Intern Med (1990) 1.68
Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol (2000) 1.66
A postprophase topoisomerase II-dependent chromatid core separation step in the formation of metaphase chromosomes. J Cell Biol (1995) 1.65
Cholera in Lima, Peru, correlates with prior isolation of Vibrio cholerae from the environment. Am J Epidemiol (1997) 1.65
Vibrio metschnikovii bacteremia in a patient with cholecystitis. J Clin Microbiol (1981) 1.65
UBA domains mediate protein-protein interactions between two DNA damage-inducible proteins. J Mol Biol (2001) 1.60
Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as one route of transmission. J Infect Dis (1993) 1.59
Obturator hernia: a new technique for repair. J R Coll Surg Edinb (1998) 1.58
Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect Immun (2001) 1.58
Effect of metronidazole on hydrogen production by Clostridium acetobutylicum. Arch Mikrobiol (1972) 1.57
The total antioxidant capacity of human serum measured using enhanced chemiluminescence is almost completely accounted for by urate. Ann Clin Biochem (1997) 1.57
Spo0A directly controls the switch from acid to solvent production in solvent-forming clostridia. Mol Microbiol (2000) 1.55
Mutations in the extracellular protein secretion pathway genes (eps) interfere with rugose polysaccharide production in and motility of Vibrio cholerae. Infect Immun (2000) 1.50
The neuropsychology of de novo patients with idiopathic Parkinson's disease: the effects of age of onset. Int J Neurosci (1989) 1.49
Detection by immune electron microscopy of 27-nm viral particles associated with community-acquired diarrhea in children. J Infect Dis (1990) 1.48
Capsular types of Vibrio vulnificus: an analysis of strains from clinical and environmental sources. J Infect Dis (1993) 1.47
Use of colistin-polymyxin B-cellobiose agar for isolation of Vibrio vulnificus from the environment. Appl Environ Microbiol (1992) 1.45
Persistence of cholera in the United States: isolation of Vibrio cholerae O1 from a patient with diarrhea in Maryland. J Clin Microbiol (1986) 1.44
Chlorine and survival of "rugose" Vibrio cholerae. Lancet (1992) 1.43
Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis (2007) 1.43
Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science (1987) 1.42
Handcuff neuropathy involving the dorsal ulnar cutaneous nerve. Muscle Nerve (1993) 1.40
An outbreak of cholera in Maryland associated with imported commercial frozen fresh coconut milk. J Infect Dis (1993) 1.39
Confusion, cortical blindness and fever. Med J Aust (1995) 1.38
The biosynthesis of granulose by Clostridium pasteurianum. Biochem J (1974) 1.37
Phylogeny of Vibrio cholerae based on recA sequence. Infect Immun (2000) 1.37
Differential expression of Vibrio vulnificus capsular polysaccharide. Infect Immun (1999) 1.36
Isolation of nontoxigenic Vibrio cholerae O group 1 from a patient with severe gastrointestinal disease. J Clin Microbiol (1984) 1.35
Non-O group 1 Vibrio cholerae gastroenteritis associated with eating raw oysters. Am J Epidemiol (1981) 1.35
Epidemiology and spectrum of Vibrio infections in a Chesapeake Bay community. J Infect Dis (1989) 1.31
The stage is set for the diffusion of positron emission tomography (PET) in oncology. Med J Aust (1999) 1.30
Utilization of L-threnonine by a pseudomonad: a catabolic role for L-threonine aldolase. Biochem J (1969) 1.29
Purification of two Clostridium bacteriocins by procedures appropriate to hydrophobic proteins. Antimicrob Agents Chemother (1975) 1.28
Cyclin-dependent kinase and Cks/Suc1 interact with the proteasome in yeast to control proteolysis of M-phase targets. Genes Dev (1999) 1.28
Pyruvate carboxylase in Rhodopseudomonas spheroides. J Gen Microbiol (1969) 1.27
Vibrio vulnificus septicemia. Isolation of organism from stool and demonstration of antibodies by indirect immunofluorescence. Arch Intern Med (1983) 1.26
Identification of genes controlling growth polarity in the budding yeast Saccharomyces cerevisiae: a possible role of N-glycosylation and involvement of the exocyst complex. Genetics (1997) 1.25
Molecular epidemiology of neonatal meningitis due to Citrobacter diversus: a study of isolates from hospitals in Maryland. J Infect Dis (1986) 1.23
Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp Brain Res (1988) 1.23
The proton-translocating adenosine triphosphatase of the obligately anaerobic bacterium Clostridium pasteurianum. 1. ATP phosphohydrolase activity. Eur J Biochem (1979) 1.23
Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity. Clin Diagn Lab Immunol (1997) 1.23
Epidemiology of antimicrobial resistant cholera in Kenya and East Africa. Am J Trop Med Hyg (1988) 1.22
Regeneration of protoplasts of Clostridium pasteurianum ATCC 6013. J Bacteriol (1983) 1.20
Development of an in vitro model for study of non-O1 Vibrio cholerae virulence using Caco-2 cells. Infect Immun (1990) 1.20
Clb5-associated kinase activity is required early in the spindle pathway for correct preanaphase nuclear positioning in Saccharomyces cerevisiae. J Cell Biol (1998) 1.19
Fifth Stenhous-Williams memorial lecture. Oxygen and the obligate anaerobe. J Appl Bacteriol (1976) 1.19
Proton-motive force in the obligately anaerobic bacterium Clostridium pasteurianum: a role in galactose and gluconate uptake. FEBS Lett (1975) 1.19
Survival and differentiation of rat and human epidermal growth factor-responsive precursor cells following grafting into the lesioned adult central nervous system. Exp Neurol (1996) 1.18
A video review of the diagnosis of psychogenic gait: appendix and commentary. Mov Disord (1999) 1.18
Lack of hepatic enzymatic adaptation to low and high levels of dietary protein in the adult cat. Enzyme (1977) 1.17
Carbohydrate digestion by the domestic cat (Felis catus). Br J Nutr (1977) 1.16
Clozapine treatment of psychosis associated with velo-cardio-facial syndrome: benefits and risks. J Intellect Disabil Res (2005) 1.16
The pbgPE operon in Photorhabdus luminescens is required for pathogenicity and symbiosis. J Bacteriol (2005) 1.15
Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models. Infect Immun (1997) 1.15